» Authors » Sirinporn Suksawatamnuay

Sirinporn Suksawatamnuay

Explore the profile of Sirinporn Suksawatamnuay including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 22
Citations 101
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Thanapirom K, Suksawatamnuay S, Thaimai P, Ananchuensook P, Kijrattanakul P, Angchaisuksiri P, et al.
Thromb Haemost . 2025 Jan; PMID: 39788529
Background:  Clot waveform analysis (CWA) provides a global assessment of hemostasis and may be useful for patients with cirrhosis with complex hemostatic abnormalities. This study aimed to assess the association...
2.
Wejnaruemarn S, Suksawatamnuay S, Vanichanan J, Komolmit P, Treeprasertsuk S, Thanapirom K
PLoS One . 2024 Dec; 19(12):e0315619. PMID: 39724169
Background & Aims: Acute-on-chronic liver failure is a syndrome characterized by organ failure and high short-term mortality. The lack of reliable biomarkers for the early detection of acute-on-chronic liver failure...
3.
Thanapirom K, Suksawatamnuay S, Wejnaruemarn S, Thaimai P, Siripon N, Ananchuensook P, et al.
Clin Transl Gastroenterol . 2024 Mar; 15(5):e00697. PMID: 38488171
Introduction: Data on the relationship between bacterial translocation, hepatic encephalopathy (HE), and mortality are scarce. This study aimed to assess the association between bacterial DNA (bactDNA) translocation, inflammatory response, ammonia...
4.
Ananchuensook P, Suksawatamnuay S, Thaimai P, Siripon N, Sriphoosanaphan S, Thanapirom K, et al.
Sci Rep . 2023 Dec; 13(1):22633. PMID: 38114689
Knowledge about the epidemiology of hepatitis D virus (HDV) is essential for effective screening and management. Our study aimed to update the prevalence of HDV infection among patients with hepatitis...
5.
Thanapirom K, Wongwandee M, Suksawatamnuay S, Thaimai P, Siripon N, Makhasen W, et al.
J Clin Med . 2023 Jan; 12(2). PMID: 36675448
The psychometric hepatic encephalopathy score (PHES) is the gold standard for diagnosing minimal hepatic encephalopathy (MHE). Screening for MHE is frequently overlooked in clinical practice due to time constraints. Furthermore,...
6.
Sriphoosanaphan S, Suksawatamnuay S, Srisoonthorn N, Siripon N, Thaimai P, Ananchuensook P, et al.
Vaccines (Basel) . 2022 Dec; 10(12). PMID: 36560535
Background: Heterologous prime-boost vaccination potentially augments the immune response against SARS-CoV-2 in liver transplant (LT) recipients. We investigated immunogenicity induced by different primary prime-boost vaccination protocols and the subsequent response...
7.
Thanapirom K, Suksawatamnuay S, Thaimai P, Treeprasertsuk S, Komolmit P, Tangkijvanich P
Front Med (Lausanne) . 2022 Nov; 9:995857. PMID: 36330056
Background And Aims: Access to Hepatitis B virus (HBV) DNA testing to determine treatment eligibility is limited in low-income countries. Therefore, this study aimed to assess and validate the TREAT-B...
8.
Thanapirom K, Suksawatamnuay S, Tanpowpong N, Chaopathomkul B, Sriphoosanaphan S, Thaimai P, et al.
Sci Rep . 2022 Mar; 12(1):4913. PMID: 35318425
There is an urgent need of non-invasive tests (NITs) for monitoring treatment response and disease progression in chronic liver disease. Liver stiffness (LS) evaluated by transient elastography (TE), shear wave...
9.
Rattanachaisit P, Suksawatamnuay S, Sriphoosanaphan S, Thanapirom K, Thaimai P, Siripon N, et al.
PeerJ . 2021 May; 9:e11207. PMID: 33954043
Background: Hepatitis B virus (HBV) pregenomic RNA (pgRNA) has gained increasing attention owing to its role in replication of covalently closed circular DNA (cccDNA) in HBV. This marker has the...
10.
Sriphoosanaphan S, Thanapirom K, Kerr S, Suksawatamnuay S, Thaimai P, Sittisomwong S, et al.
PeerJ . 2021 Feb; 9:e10709. PMID: 33614272
Background: Replacement of vitamin D (VD) among patients with chronic hepatitis C (CHC) before viral eradication has demonstrated a protective effect on serum markers associated with hepatic fibrogenesis. We therefore...